litlas
Log inCreate account

Joan L. Walker

Active 1984–2025

128
Papers
24,093
Citations
81
h-index
118
i10-index

Citations

Citations per year for Joan L. Walker1976: 2 citations1982: 1 citations1986: 1 citations1987: 1 citations1988: 6 citations1989: 3 citations1990: 8 citations1991: 9 citations1992: 4 citations1993: 8 citations1994: 11 citations1995: 10 citations1996: 11 citations1997: 13 citations1998: 12 citations1999: 14 citations2000: 24 citations2001: 33 citations2002: 45 citations2003: 40 citations2004: 31 citations2005: 47 citations2006: 70 citations2007: 114 citations2008: 60 citations2009: 94 citations2010: 101 citations2011: 118 citations2012: 146 citations2013: 109 citations2014: 108 citations2015: 129 citations2016: 152 citations2017: 136 citations2018: 171 citations2019: 553 citations2020: 591 citations2021: 507 citations2022: 369 citations2023: 314 citations2024: 466 citations2025: 205 citations2026: 11 citations1977–1981: no citations, so these years are not shown1983–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,741 citing papers, 27.5% of this breakdownChina: 517 citing papers, 8.1% of this breakdownUnited Kingdom: 387 citing papers, 6.1% of this breakdownItaly: 336 citing papers, 5.3% of this breakdownCanada: 270 citing papers, 4.3% of this breakdownFrance: 233 citing papers, 3.7% of this breakdownGermany: 222 citing papers, 3.5% of this breakdownJapan: 203 citing papers, 3.2% of this breakdownNetherlands: 198 citing papers, 3.1% of this breakdownAustralia: 176 citing papers, 2.8% of this breakdownSpain: 165 citing papers, 2.6% of this breakdownIndia: 147 citing papers, 2.3% of this breakdown
0%27.5%Other 27.5%

Institutions

Fields

  • Medicine70.8%
  • Biochemistry, Genetics and Molecular Biology12.2%
  • Social Sciences3.1%
  • Engineering2.2%
  • Computer Science2.2%
  • Immunology and Microbiology1.9%
  • Other7.6%

Topics

  • Endometrial and Cervical Cancer Treatments11.1%
  • Ovarian cancer diagnosis and treatment9.4%
  • Cervical Cancer and HPV Research6.8%
  • Intraperitoneal and Appendiceal Malignancies3.2%
  • PARP inhibition in cancer therapy2.5%
  • Gynecological conditions and treatments1.8%
  • Other65.2%

Coauthors

All papers

Open in search
  1. Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

    Authors: Robert L. Coleman, Mark F. Brady, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Joan L. Walker, Byoung‐Gie Kim, Keiichi Fujiwara, Krishnansu S. Tewari, David M. O’Malley, Susan A. Davidson, Stephen C. Rubin, Paul DiSilvestro, Karen Basen‐Engquist, Helen Huang, John K. Chan, Nick M. Spirtos, Raheela Ashfaq, Robert S. Mannel - The Lancet Oncology 2017 cited by 602

  2. Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening

    Authors: Nicolas Wentzensen, Bernd Lahrmann, Megan A. Clarke, Walter Kinney, Diane Tokugawa, Nancy Poitras, Alex Locke, Liam Bartels, Alexandra Krauthoff, Joan L. Walker, Rosemary E. Zuna, Kiranjit Grewal, Patricia Goldhoff, Julie D Kingery, Philip E. Castle, Mark Schiffman, Thomas Lorey, Niels Grabe - JNCI Journal of the National Cancer Institute 2020 cited by 169

  3. Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

    Authors: Deborah K. Armstrong, Brian N. Bundy, Lari Wenzel, Helen Huang, Rebecca N. Baergen, Shashikant Lele, Larry J. Copeland, Joan L. Walker, Robert A. Burger - New England Journal of Medicine 2006 cited by 2,625

  4. Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

    Authors: Robert L. Coleman, Nick M. Spirtos, Danielle Enserro, Thomas J. Herzog, Paul Sabbatini, Deborah K. Armstrong, Jae‐Weon Kim, Sang‐Yoon Park, Byoung‐Gie Kim, Joo-Hyun Nam, Keiichi Fujiwara, Joan L. Walker, A.Catherine Casey, Angeles Alvarez Secord, Steve Rubin, John K. Chan, Paul DiSilvestro, Susan A. Davidson, David E. Cohn, Krishnansu S. Tewari, Karen Basen‐Engquist, Helen Huang, Mark F. Brady, Robert S. Mannel - New England Journal of Medicine 2019 cited by 334

  5. A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study

    Authors: Brian M. Slomovitz, Virginia L. Filiaci, Joan L. Walker, Michael C. Taub, Karen A. Finkelstein, John W. Moroney, Aimee C. Fleury, Carolyn Y. Muller, Laura L. Holman, Larry J. Copeland, David S. Miller, Robert L. Coleman - Gynecologic Oncology 2022 cited by 71

  6. Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2

    Authors: Joan L. Walker, Marion Piedmonte, Nick M. Spirtos, Scott M. Eisenkop, John B. Schlaerth, Robert S. Mannel, Gregory Spiegel, Richard R. Barakat, Michael L. Pearl, Sudarshan Sharma - Journal of Clinical Oncology 2009 cited by 1,295

  7. Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study

    Authors: Joan L. Walker, Marion R. Piedmonte, Nick M. Spirtos, Scott M. Eisenkop, John B. Schlaerth, Robert S. Mannel, Richard R. Barakat, Michael L. Pearl, Sudarshan Sharma - Journal of Clinical Oncology 2012 cited by 778

  8. Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

    Authors: Henry Keys, Brian N. Bundy, Frederick B. Stehman, Laila I. Muderspach, Weldon Chafe, Charles L. Suggs, Joan L. Walker, Deborah J. Gersell - New England Journal of Medicine 1999 cited by 1,947

  9. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis

    Authors: Lisa Mirabello, Meredith Yeager, Kai Yu, Gary M. Clifford, Yanzi Xiao, Bin Zhu, Michael Cullen, Joseph F. Boland, Nicolas Wentzensen, Chase W. Nelson, Tina Raine‐Bennett, Zigui Chen, Sara Bass, Lei Song, Qi Yang, Mia Steinberg, Laurie Burdett, Michael Dean, David A. Roberson, Jason Mitchell, Thomas Lorey, Silvia Franceschi, Philip E. Castle, Joan L. Walker, Rosemary E. Zuna, Aimée R. Kreimer, Daniel C. Beachler, Allan Hildesheim, Paula González, Carolina Porras, Robert D. Burk, Mark Schiffman - Cell 2017 cited by 306

  10. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

    Authors: John K. Chan, Mark F. Brady, Richard T. Penson, Helen Huang, Michael J. Birrer, Joan L. Walker, Paul DiSilvestro, Stephen C. Rubin, Lainie P. Martin, Susan A. Davidson, Warner K. Huh, David M. O’Malley, Matthew Boente, Helen Michael, Bradley J. Monk - New England Journal of Medicine 2016 cited by 367

  11. Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy

    Authors: Nicolas Wentzensen, Joan L. Walker, Michael A. Gold, Katie Smith, Rosemary E. Zuna, Cara Mathews, S. Terence Dunn, Roy Zhang, Katherine Moxley, Erin Bishop, Meaghan Tenney, Elizabeth Nugent, Barry I. Graubard, Sholom Wacholder, Mark Schiffman - Journal of Clinical Oncology 2014 cited by 229

  12. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention

    Authors: Maísa Pinheiro, Julia C. Gage, Gary M. Clifford, Maria Demarco, Li C. Cheung, Zigui Chen, Meredith Yeager, Michael Cullen, Joseph F. Boland, Xiaojian Chen, Tina Raine‐Bennett, Mia Steinberg, Sara Bass, Brian Befano, Yanzi Xiao, Vanessa Tenet, Joan L. Walker, Rosemary E. Zuna, Nancy Poitras, Michael A. Gold, T.S. Dunn, Kai Yu, Bin Zhu, Laurie Burdett, Sevilay Turan, Thomas Lorey, Philip E. Castle, Nicolas Wentzensen, Robert D. Burk, Mark Schiffman, Lisa Mirabello - International Journal of Cancer 2020 cited by 85

  13. Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study

    Authors: Benoît You, Christopher Purdy, Larry J. Copeland, Elizabeth M. Swisher, Michael A. Bookman, Gini F. Fleming, Robert L. Coleman, Leslie M. Randall, Krishnansu S. Tewari, Bradley J. Monk, Robert S. Mannel, Joan L. Walker, Fabio Cappuccini, David E. Cohn, Mahvish Muzaffar, David G. Mutch, Andrea E. Wahner Hendrickson, Lainie P. Martin, Olivier Colomban, Robert A. Burger - Journal of Clinical Oncology 2022 cited by 75

  14. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling

    Authors: Johan A. den Boon, Dohun Pyeon, Sophia Wang, Mark Horswill, Mark Schiffman, Mark E. Sherman, Rosemary E. Zuna, Zhishi Wang, Stephen M. Hewitt, Rachel Pearson, Meghan Schott, Lisa Chung, Qiuling He, Paul F. Lambert, Joan L. Walker, Michael A. Newton, Nicolas Wentzensen, Paul Ahlquist - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 311

  15. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

    Authors: Andreas Obermair, Rebecca Asher, René Pareja, Michael Frumovitz, Aldo López, Renato Moretti‐Marques, Gabriel Jaime Rendón-Pereira, Reitan Ribeiro, Audrey Tieko Tsunoda, Vanessa Behan, Alessandro Buda, Marcus Q. Bernadini, Hongqin Zhao, Marcelo de Andrade Vieira, Joan L. Walker, Nick M. Spirtos, Shuzhong Yao, Naven Chetty, Tao Zhu, David Isla, Mariano Tamura, James Nicklin, Kristy Robledo, Val Gebski, Robert L. Coleman, Gloria Salvo, Pedro T. Ramírez - American Journal of Obstetrics and Gynecology 2019 cited by 142

  16. Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial

    Authors: Robert S. Krouse, Garnet L. Anderson, Kathryn B. Arnold, Cynthia A. Thomson, Valentine Nfonsam, Mazin F Al-Kasspooles, Joan L. Walker, Virginia Sun, Angeles Alvarez Secord, Ernest Han, Alberto M. León-Takahashi, David Isla‐Ortiz, Phillip Rodgers, Samantha Hendren, M Salcedo, Jonathan Laryea, Whitney A. Spannuth Graybill, Devin C. Flaherty, Harveshp Mogal, Thomas J. Miner, José M. Pimiento, Mio Kitano, Brian D. Badgwell, Giles F. Whalen, Jeffrey P. Lamont, Óscar Guevara, Maheswari Senthil, Summer Dewdney, Eric J. Silberfein, Jason D. Wright, Bret Edward Buckley Friday, Bridget N. Fahy, Sandeep Anantha Sathyanarayana, Mark Allen O’Rourke, Marie Bakitas, Jeff A. Sloan, Marcia Grant, Gary B. Deutsch, Jeremiah L. Deneve - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 50

  17. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

    Authors: Steven J. Skates, Mark H. Greene, Saundra S. Buys, Phuong L. Mai, Powel Brown, Marion Piedmonte, Gustavo C. Rodriguez, John O. Schorge, Mark E. Sherman, Mary B. Daly, Thomas F. Rutherford, Wendy R. Brewster, David M. O’Malley, Edward E. Partridge, John F. Boggess, Charles W. Drescher, Claudine Isaacs, Andrew Berchuck, Susan M. Domchek, Susan A. Davidson, Robert P. Edwards, Steven A. Elg, Katie Wakeley, Kelly‐Anne Phillips, Deborah K. Armstrong, Ira Horowitz, Carol J. Fabian, Joan L. Walker, Patrick M. Sluss, William J. Welch, Lori M. Minasian, Nora Horick, Carol H. Kasten, Susan Nayfield, David S. Alberts, Dianne M. Finkelstein, Karen H. Lu - Clinical Cancer Research 2017 cited by 139

  18. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

    Authors: Joan L. Walker, Mark F. Brady, Lari Wenzel, Gini F. Fleming, Helen Huang, Paul DiSilvestro, Keiichi Fujiwara, David S. Alberts, Wenxin Zheng, Krishnansu S. Tewari, David E. Cohn, Matthew A. Powell, Linda Van Le, Susan A. Davidson, Heidi J. Gray, Peter G. Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C. Rubin, Robert S. Mannel - Journal of Clinical Oncology 2019 cited by 232

  19. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients

    Authors: Jay W. Carlson, James Kauderer, Alan D. Hutson, Jeanne Carter, Jane M. Armer, Suzy Lockwood, Susan Nolte, Bob R. Stewart, Lari Wenzel, Joan L. Walker, Aimee C. Fleury, Albert J. Bonebrake, John T. Soper, Cara Mathews, Oliver Zivanovic, W. E. Richards, Annie Tan, David S. Alberts, Richard R. Barakat - Gynecologic Oncology 2019 cited by 126

  20. A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional study

    Authors: Federica Inturrisi, Sílvia de Sanjosé, Kanan Desai, Casey Dagnall, Didem Egemen, Brian Befano, Ana Cecilia Rodríguez, José Jerónimo, Rosemary E. Zuna, Amanda Hoffman, Sepideh Farhat Nozzari, Joan L. Walker, Rebecca B. Perkins, Nicolas Wentzensen, Joel M. Palefsky, Mark Schiffman - International Journal of Cancer 2023 cited by 34

  21. Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management

    Authors: Rachel N. Grisham, Bonnie Ky, Krishnansu S. Tewari, David J. Chaplin, Joan L. Walker - Gynecologic Oncology Research and Practice 2018 cited by 106

  22. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women

    Authors: Gary M. Clifford, Vanessa Tenet, Damien Georges, Laia Alemany, Miguel Ángel Pavón, Zigui Chen, Meredith Yeager, Michael Cullen, Joseph F. Boland, Sara Bass, Mia Steinberg, Tina Raine‐Bennett, Thomas Lorey, Nicolas Wentzensen, Joan L. Walker, Rosemary E. Zuna, Mark Schiffman, Lisa Mirabello - Papillomavirus Research 2019 cited by 98

  23. Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

    Authors: David E. Cohn, Michael W. Sill, Joan L. Walker, David M. O’Malley, Christa Nagel, Teresa Rutledge, William H. Bradley, Debra L. Richardson, Katherine Moxley, Carol Aghajanian - Gynecologic Oncology 2017 cited by 78

  24. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study

    Authors: Jeffrey G. Bell, Mark F. Brady, Robert C. Young, Janice M. Lage, Joan L. Walker, Katherine Y. Look, G. Scott Rose, Nick M. Spirtos - Gynecologic Oncology 2006 cited by 308